Earlier i attempted to Insurance Risk with the high concentrations some of the 2012 we were significantly blow we have four of those cases if we acknowledge that were going always going to see that having said that, were going to manage those and manage the overall care the headwinds are not going away were phasing every one the doctors will have their rent tripled the the overhead money spent needs to be reduced we are going to use metrics to have the bed moved from the low 2 hundred in aggregate needs to be down in the 145 or one 90 i did not introduce we vp have an additional to the ucsf dignity house our colleagues from mp c that share a commitment im submit across the board we have achieved the goal of length i didnt stay down closer to the 4 rage and another reduction on the pharmacy side weve talked about jen ice cream were 13 to but we need to do that and as ann marie said the subsets of patient that are very, very expensive if you shave 57 and 10 percent off by not achieving h
Theyre being bought by a Larger Company so you have many of the measuring companies now becoming more mainstream, if you will, as a result may be one to 3 options before you had as many as 678 that raises the costs secondly fall because of the new regulations drug shortages jen ice cream continues to balance the budget we need them to grow you have to remember they represent only thirty percent of the costs you have another 70 percent that needs to be managed if that leads me to my last slide the pharmaceutical management will be critical in the future we need to foster competition that works not people to set prices based on with no reason we need optimal utilization by members most people fail to follow their drug regiment we need to make it a value based payment and coverage policy you are getting the best benefit for following your drugs and make sure that all the costs are transparent so people know what their bowing and increase the medication adherence and make sure we have the
If you dont mind can i do them in a little bit of resources order and on a couple of them examinations for 2015 indulge you to have our head of the program the people speak to those with me i think your commitment to this as youve heard me over the years were all in we building in foich fif and the uniqueness of the patients with us the main thing for us as we go to things well do next ill work my way up to the questions weve had good success are activities youve heard me described impacting the managing disease and applications more effectively weve shown a trend a significant reduction weve shown increase in excuse me. A daers if e. R. Patient are better managed and shown increase in genetic compliance on the pharmacy side and next move to other sites of care more inches for the board burner activity to continue and double down and continue to do those are things but increase those are working with our Hospital Partners i believe ive speaking for both but working with the Hospital Pa
In aggregate needs to be down in the 145 or one 90 i did not introduce we vp have an additional to the ucsf dignity house our colleagues from mp c that share a commitment im submit across the board we have achieved the goal of length i didnt stay down closer to the 4 rage and another reduction on the pharmacy side weve talked about jen ice cream were 13 to but we need to do that and as ann marie said the subsets of patient that are very, very expensive if you shave 57 and 10 percent off by not achieving having a better clinic outcome and save thousands of dollars in the episodes of treatment those are the activities well put in place as i said the last 3 years have been a year of success across the board it is down 10 percent from we were a few years ago that is not down from an increase but an actual how many patient per population adjustorer had to be not limited to to the hospital our rate the er visit rates have gone up dramatically it is a Financial Result were not so proud of but
My last slide the pharmaceutical management will be critical in the future we need to foster competition that works not people to set prices based on with no reason we need optimal utilization by members most people fail to follow their drug regiment we need to make it a value based payment and coverage policy you are getting the best benefit for following your drugs and make sure that all the costs are transparent so people know what their bowing and increase the medication adherence and make sure we have the data so we can address the gaps in care and make sure that if a drug can be administered at a site we go to the lower site if you can take it at home or at the Physicians Office not going to the hospital it is 2 hundred percent higher and in closing you also have to remember the person that is taking the speciality drugs those individuals not only are they bearing a high cost of the drugs they have that but they also represent about 25 percent of the medical so they have medical